Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB1518 (Pacritinib) in Chronic Idiopathic Myelofibrosis
NCT00745550Phase 2Completed
- Sponsor
- S*BIO
- Start
- Aug 2008
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pacritinib in myelofibrosis (MF), sponsored by S*BIO. Started Aug 2008; status: completed.
02
Drugs
pacritinib
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT00745550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00745550.